An evaluation of a distributed medical device safety surveillance system: The DELTA network study

Contemporary Clinical Trials

Volumn 32, Issue 3, 2011, Pages 309-317

  Vidi, Venkatesan D ^a   Matheny, Michael E ^b,c,d   Donnelly, Sharon ^a   Resnic, Frederic S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Veterans Administration   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Interventional cardiology; Network study; Post market surveillance; Safety surveillance

Indexed keywords

ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; COMPUTER NETWORK; CORONARY ARTERY DISEASE; CORONARY STENT; DATA ANALYSIS; DATA BASE; DEVICE; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; EMBOLISM; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LONGITUDINAL STUDY; MEDICAL AUDIT; MEDICAL SOCIETY; MORTALITY; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTMARKETING SURVEILLANCE; PREDICTIVE VALUE; REGISTER; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VASCULAR CLOSURE DEVICE;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; COMPUTER COMMUNICATION NETWORKS; CONFIDENTIALITY; DATA MINING; DATABASES, FACTUAL; DRUG-ELUTING STENTS; EMBOLIC PROTECTION DEVICES; ENDOVASCULAR PROCEDURES; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; REGISTRIES; YOUNG ADULT;

EID: 79953050583     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2011.02.001     Document Type: Article

References (32)

1. Platt R., Wilson M., Chan K.A., Benner J.S., Marchibroda J., McClellan M. The new Sentinel Network-improving the evidence of medical-product safety. N Engl J Med Aug 13 2009, 361(7):645-647.
2. The Sentinel Initiative: a national strategy for monitoring medical product safety Accessed February 3, 2010, at. http://www.fda.gov/downloads/Safety/FDAsSentinelInitiative/UCM124701.pdf.
3. Baim D.S., Mehran R., Kereiakes D.J., Gross T.P., Simons M., Malenka D., et al. Postmarket surveillance for drug-eluting coronary stents: a comprehensive approach. Circulation Feb 14 2006, 113(6):891-897.
4. Manufacturer, User Facility Device Experience Database - (MAUDE) Accessed February 3, 2010, at. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/ReportingAdverseEvents/ucm127891.htm.
5. Massachusetts Data access center (MASS-DAC) Percutaneous coronary intervention Cohort timeline summary Accessed February 3, 2010, at. http://www.massdac.org/pci.
6. Matheny M.E., Ohno-Machado L., Resnic F.S. Monitoring device safety in interventional cardiology. J Am Med Inform Assoc Mar-Apr 2006, 13(2):180-187.
7. Arora N., Matheny M.E., Sepke C., Resnic F.S. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J Apr 2007, 153(4):606-611.
8. Matheny M.E., Morrow D.A., Ohno-Machado L., Cannon C.P., Sabatine M.S., Resnic F.S. Validation of an automated safety surveillance system with prospective, randomized trial data. Med Decis Making Mar-Apr 2009, 29(2):247-256.
9. Matheny M.E., Arora N., Ohno-Machado L., Resnic F.S. Rare adverse event monitoring of medical devices with the use of an automated surveillance tool. AMIA Annu Symp Proc 2007, 518-522.
10. Gostin L.O. National health information privacy: regulations under the Health Insurance Portability and Accountability Act. JAMA Jun 20 2001, 285(23):3015-3021.
11. Cannon C.P., Battler A., Brindis R.G., Cox J.L., Ellis S.G., Every N.R., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol Dec 2001, 38(7):2114-2130.
12. American College of Cardiology's National Cardiovascular Data Registry's instrument Accessed February 3, 2010, at. http://www.accncdr.com/WebNCDR/ELEMENTS.ASPX.
13. Massachusetts Cardiac Study: process of completing final public reports on PCI Accessed May 25, 2010 at. http://massdac.org/sites/default/files/reports/FlowchartMassDACSteps.pdf.
14. Securing SQL Server Accessed February 3, 2010, at. http://msdn.microsoft.com/en-us/library/bb283235(SQL.90).aspx.
15. Rosenbaum P., Ruben D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
16. Brookhart M.A., Schneeweiss S., Rothman K.J., Glynn R.J., Avorn J., Sturmer T. Variable selection for propensity score models. Am J Epidemiol Jun 15 2006, 163(12):1149-1156.
17. Cepeda M.S., Boston R., Farrar J.T., Strom B.L. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol Aug 1 2003, 158(3):280-287.
18. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med Apr 30 1998, 17(8):873-890.
19. Austin P.C. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J Feb 2009, 51(1):171-184.
20. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med Apr 30 1998, 17(8):857-872.
21. O'Brien P.C., Fleming T.R. A multiple testing procedure for clinical trials. Biometrics Sep 1979, 35(3):549-556.
22. Resnic F.S., Zou K.H., Do D.V., Apostolakis G., Ohno-Machado L. Exploration of a Bayesian updating methodology to monitor the safety of interventional cardiovascular procedures. Med Decis Making Jul-Aug 2004, 24(4):399-407.
23. Matheny M.E., Ohno-Machado L., Resnic F.S. Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology. Am Heart J Jan 2008, 155(1):114-120.
24. Spiegelhalter D., Grigg O., Kinsman R., Treasure T. Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. Int J Qual Health Care Feb 2003, 15(1):7-13.
25. Steiner S.H., Cook R.J., Farewell V.T., Treasure T. Monitoring surgical performance using risk-adjusted cumulative sum charts. Biostatistics Dec 2000, 1(4):441-452.
26. Mass-DAC data submission and report timelines, Report Timelines Accessed May 25, 2010 at. http://massdac.org/sites/default/files/PCITimelines.pdf.
27. Gross T.P., Kessler L.G. Medical device vigilance at FDA. Stud Health Technol Inform 1996, 28:17-24.
28. Samore M.H., Evans R.S., Lassen A., Gould P., Lloyd J., Gardner R.M., et al. Surveillance of medical device-related hazards and adverse events in hospitalized patients. JAMA Jan 21 2004, 291(3):325-334.
29. Maisel W.H. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med Mar 8 2007, 356(10):981-984.
30. Shah J.S., Maisel W.H. Recalls and safety alerts affecting automated external defibrillators. JAMA Aug 9 2006, 296(6):655-660.
31. Resnic F.S., Gross T.P., Marinac-Dabic D., Loyo-Berrios N., Donnelly S., Normand S.L., et al. Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA Nov 10 2010, 304(18):2019-2027.
32. Managing risks from medical product use: creating a risk management framework. Report to the FDA Commissioner from the Task Force on Risk Management 2001, U.S. Department of Health 26. 105 Code of Massachusetts Regulations. Department of Public Health, Rockville, MD, 130.1201-130.130.